Last updated: January 31, 2023
Sponsor: Assiut University
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Lupus
Anemia
Red Blood Cell Disorders
Treatment
N/AClinical Study ID
NCT05711264
CD4+CD28- Lymphocyte IN AIHA
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 1- newly diagnosed patients with AIHA 2- patients with idiopathic or secondary AIHA
Exclusion
Exclusion Criteria:
- 1-current steroid therapy 2- other concurrent chronic inflammatory conditions 3-recentblood transfusion 4- active Hepatitis C virus
Study Design
Total Participants: 46
Study Start date:
January 30, 2023
Estimated Completion Date:
April 01, 2025